Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FTKQH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48,749.85 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of September 19, 2025, carries no set-aside designation and represents a continuation of DMS Pharmaceutical Group's significant role as a critical supplier within the federal pharmaceutical supply chain. The contract is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026.
The DLA's SPE2DB indefinite delivery contract with DMS Pharmaceutical Group enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military healthcare facilities worldwide. Stelara, a specialty biologic medication, exemplifies the types of branded pharmaceutical products that DMS Pharmaceutical Group routinely supplies to Department of Defense healthcare sites as part of its established federal contract portfolio, which also encompasses prescription medications, over-the-counter drugs, biologics, and medical consumables. This delivery order reflects the vendor's consistent ability to compete effectively in federal procurement markets and maintain its position as a key distributor of specialty pharmaceutical products to military health systems.
Quick answers
Who was awarded contract SPE2DB25FTKQH?
SPE2DB25FTKQH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FTKQH worth?
The government has obligated $48,750 on SPE2DB25FTKQH.
Is contract SPE2DB25FTKQH an order under another contract?
Yes. SPE2DB25FTKQH is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKQH competed?
The extent of competition for SPE2DB25FTKQH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award